The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Alere Inc

NYSE: ALR
Last

(U.S.) $51.58

Today's change+0.22 +0.43%
Updated May 29 4:03 PM EDT. Delayed by at least 15 minutes.
 

Alere Inc

NYSE: ALR
Last

(U.S.) $51.58

Today's change+0.22 +0.43%
Updated May 29 4:03 PM EDT. Delayed by at least 15 minutes.

Alere Inc Hits New 52-week High

Alere Inc closed up Friday by (U.S.)$0.22 or 0.43% to (U.S.)$51.58 and setting a new 52-week high. Over the last five days, shares have gained 0.55% and 35.74% year to date. Shares have outperformed the S&P 500 by 34.44% during the last year.

Key company metrics

  • Open(U.S.) $51.29
  • Previous close(U.S.) $51.36
  • High(U.S.) $51.98
  • Low(U.S.) $50.91
  • Bid / Ask-- / --
  • YTD % change+35.74%
  • Volume421,336
  • Average volume (10-day)366,894
  • Average volume (1-month)371,878
  • Average volume (3-month)466,418
  • 52-week range(U.S.) $33.76 to (U.S.) $51.98
  • Beta1.99
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward21.02×
  • Forward PEG2.10×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.24
Updated May 29 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-7.32%

Although this company's net profit margin is negative, it is above the industry average and implies that Alere Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.62%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue610397736738
Total other revenue--------
Total revenue610397736738
Gross profit296191349340
Total cost of revenue315206388398
Total operating expense581366699747
Selling / general / administrative154107260298
Research & development28293334
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)72251817
Other operating expenses, total12------
Operating income303137-9
Interest income (expense), net non-operating---53-52-52
Gain (loss) on sale of assets--------
Other--------
Income before tax-16-24-23-58
Income after tax-8-27-100-52
Income tax, total-8477-7
Net income-4152-86-50
Total adjustments to net income-5-5-5-5
Net income before extra. items-4-24-93-50
Minority interest0000
Equity in affiliates4462
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-29-99-55
Inc. avail. to common incl. extra. items-9147-92-55
Diluted net income-9147-92-55
Dilution adjustment--000
Diluted weighted average shares84848383
Diluted EPS excluding extraordinary itemsvalue per share-0.11-0.35-1.19-0.67
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.45-0.16-1.05-0.53